But sales of Spiriva, approved in chronic obstructive pulmonary disease and asthma, have declined by almost 15% although it is still BI’s biggest drug, generating sales of around 3 billion euros.

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

Novartis' Ultibro Breezhaler is one of a new generation of treatments competing to take over from standard treatments such as GSK’s Advair/Seretide, Boehringer Ingelheim’s Spiriva and ...

* From the Critical Care Department (Dr. Dimopoulos), "Attikon" University Hospital, Athens, Greece; and Alfa Institute of Biomedical Sciences (Drs. Siempos, Korbila, Manta, and Falagas), Athens ...

Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. A sustained ...

Histamine receptor, a typical G-protein-coupled receptor (GPCR), is important mediator of signalling and is responsible for regulation of human autoimmunity. Here, the authors report an artificial ...

Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...

SRS is a simple, high-efficiency, real-time media server supporting RTMP, WebRTC, HLS, HTTP-FLV, HTTP-TS, SRT, MPEG-DASH, and GB28181.